Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer Ltd
Woman and Man Max 99 years
Pfizer Ltd, Ramsgate Road Sandwich, UK
Update Il y a 4 ans
A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE EFFICACY AND TOLERABILITY OF FLEXIBLY DOSED PREGABALIN IN THE TREATMENT OF CANCER-INDUCED BONE PAIN
To assess the analgesic efficacy of flexibly-dosed Pregabalin compared with placebo, in the adjunctive treatment of subjects with cancer-induced bone pain as add-on therapy to standard-of-care opioids...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Pfizer Ltd
Update Il y a 4 ans
A MULTI-CENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO CONTROLLED PROOF OF CONCEPT AND DOSE RANGING STUDY WITH AN ACTIVE CONTROL TO ASSESS THE EFFICACY AND SAFETY/TOLERABILITY OF UK-369,003 IMMEDIATE RELEASE (IR) AND MODIFIED RELEASE (MR) IN THE TREATMENT OF MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) WITH AND WITHOUT ERECTILE DYSFUNCTION (ED)
• Compare the efficacy of the 100mg modified release (MR) and 40mg immediate release (IR) formulations of UK-369,003 vs. placebo in men suffering from LUTS with and without ED. • Characterize the dose...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd
Update Il y a 4 ans
A PHASE 2 EFFICACY AND SAFETY STUDY OF SU011248 ADMINISTERED IN A CONTINUOUS DAILY REGIMEN IN PATIENTS WITH CYTOKINE-REFRACTORY METASTATIC RENAL CELL CARCINOMA
- To evaluate the activity of SU011248 in cytokine-refractory metastatic RCC when administered in a continuous treatment regimen - To evaluate the safety and tolerability of SU011248 administered in a...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd, Ramsgate Road, Sandwich, Kent. UK
Update Il y a 4 ans
A PHASE IIA RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO AND ACTIVE CONTROLLED 5-WAY CROSS-OVER TRIAL TO EXAMINE THE BRONCHODILATOR EFFECTS OF PF-610,355 AND TO TEST FOR SUPERIORITY VERSUS PLACEBO IN REVERSIBLE ASTHMATIC PATIENTS
To test all doses of PF-610,355 for superiority of trough (24 hour post-dose) FEV1 versus placebo. To characterize the relationship of PF-610,355 dose to peak and trough FEV1
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd
Update Il y a 4 ans
A Double-blind, Proof of Concept Trial of the use of Pegvisomant to Reduce Urinary Albumin excretion in Type 1 and Type 2 Diabetic Patients treated with Angiotensin Convertase Inhibitors/Angiotensin receptor blockers, with persistent Albuminuria
To establish that Pegvisomant causes a clinically meaningful decrease in urinary albumin creatinine ratio (UACR) beyond that provided by ACEIs and ARBs. A clinically meaningful decrease is defined a...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd
Update Il y a 4 ans
A multinational, multicentre, randomized, double-blind study to assess the efficacy and safety of oral sildenafil 20mg TID or placebo when added to Bosentan in the treatement of subjects, aged 18 years and above, with pulmonary arterial hypertension (PAH)
To assess the effect on exercise capacity (as measured by the 6 Minute Walk Distance) after 12 weeks of treatment of sildenafil (20mg TID) or placebo when added to subjects with PAH who are stabilized...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Ltd
Update Il y a 4 ans
A PHASE 2B LONG-TERM, RANDOMIZED, OPEN-LABEL, SAFETY AND TOLERABILITY TRIAL COMPARING [S,S]-REBOXETINE (PNU-165442G) WITH ROUTINE CARE IN PATIENTS WITH POSTHERPETIC NEURALGIA (PHN)
To assess the long-term safety and tolerability of [S,S]-RBX in patients with PHN.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom
Update Il y a 4 ans
Study comparing the effect on disease activity when reducing or discontinuing Etanercept in subjects with Rheumatoid Arthritis (RA) (DOSERA)
To compare the effect on disease activity of the combination of ETN 50 mg QW plus methotrexate (MTX) to placebo plus MTX over 48 weeks in RA subjects who at study start are in remission or LDA state w...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd, Sandwich, UK
Update Il y a 4 ans
An eight-week, double-blind, group sequential design, placebo controlled trial to evaluate the safety and efficacy of the co-administration of sertraline and elzasonan (CP-448,187) in outpatients with major depressive disorder
To compare the efficacy of the administration of sertraline and elzasonan combination (SEC) to sertraline monotherapy in the acute treatment of subjects with MDD as measured by Montgomery-Asberg Depre...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Pfizer Ltd. Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
Update Il y a 4 ans
A PHASE 2, 16 WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, PARALLEL GROUP PROOF-OF-CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF PAIN ASSOCIATED WITH CHRONIC ABACTERIAL PROSTATITIS
To evaluate the efficacy, safety and tolerability of a single intravenous infusion of tanezumab in the treatment of pain associated with chronic prostatitis.
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
Next